Arcadia Biosciences, Inc. (RKDA) › Operating Cash FlowArcadia Biosciences, Inc. (RKDA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$13.96M2018: -$13.63M2019: -$17.20M2020: -$30.22M2021: -$25.87M2022: -$13.98M2023: -$15.29M2024: -$9.63M2025: -$4.74M-$4.74M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$4.74M+50.8%2024-$9.63M+37.1%2023-$15.29M-9.4%2022-$13.98M+46.0%2021-$25.87M+14.4%2020-$30.22M-75.7%2019-$17.20M-26.2%2018-$13.63M+2.4%2017-$13.96M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share